Hemophilia (A and B) Market 2019-2023 Analysis by Treatment Regimen, Value, Key Developments, Top Trends, and Business Strategies
Jul 8, 2019
OrbisResearch.com has published “Global Hemophilia Market Report: Insights, Trends and Forecast (2019-2023)” report to its research database. The key Players: Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited
Dallas, Texas - July 8, 2019 /MarketersMedia/ —
The global hemophilia market is estimated to reach US$12.98 billion in 2023, holding a CAGR of 6.21% in the duration spanning 2018-2023. The factors such as rise in diagnoses rate of hemophilia, rise in global healthcare expenditure and shifting focus to extended half-life (EHL) therapies are expected to drive the growth of the global hemophilia market. However, growth of the industry will be challenged by high price of treatment and reluctance to switch to new therapies. A few notable trends include shifting focus to Extended Half Life (EHL) therapies, development of novel hemophilia treatments and popularity of gene therapy.
Browse the full report@https://www.orbisresearch.com/reports/index/global-hemophilia-market-report-insights-trends-and-forecast-2019-2023
The global hemophilia market comprises of two major segments: hemophilia A and hemophilia B. hemophilia A is four time prevalent than hemophilia B. The growing incidences of hemophilia A at vast rate has driven the increased demand for anti-hemophilia A or clotting factor VIII drugs. The pharmaceutical industry is flooded with drugs to be used in the treatment of type A, and thereby providing scope for the expansion of the global hemophilia market.
The fastest growing regional market in the hemophilia space is the U.S. due to High prevalence of hemophilia, coupled with rising inclination toward prophylaxis treatment. Rise in the population of hemophilia patients, is augmenting the need for more significant treatment methods. A lot of anti-hemophilia products are available in the market and several drugs are still in their late stage clinical process by large pharmaceutical firms. Furthermore, The U.S. and Europe are the highly established premium markets that contribute to considerable shares in the global hemophilia market.
Request a sample@https://www.orbisresearch.com/contacts/request-sample/3416064
Scope of the report:
• The report provides a comprehensive analysis of the global hemophilia market, segmented into hemophilia A and hemophilia B.
• The major regional markets (the U.S. and Europe) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited) are also presented in detail.
Key Target Audience:
• Hemophilia Drugs Manufacturers
• Raw Material Suppliers
• End Users (Hospital, Medical centers, Clinical Institutes)
• Healthcare Consulting Firms
• Investment Banks
• Government Bodies & Regulating Authorities
Some points from Table of Contents:
1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia
2. Global Market Analysis
2.1 Global Hemophilia Market by Value
2.2 Global Hemophilia Market Forecast by Value
2.3 Global Hemophilia Market by Treatment Regimen
2.4 Global Hemophilia Market by Type
2.4.1 Global Hemophilia A Market Forecast by Value
2.4.2 Global Hemophilia A Market by Severity
2.4.3 Global Hemophilia A Market by Treatment Type
2.4.4 Global Hemophilia A Market by Treatment Regimen
2.4.5 Global Hemophilia B Market Forecast by Value
2.4.6 Global Hemophilia B Market by Severity
2.4.7 Global Hemophilia B Market by Treatment Type
2.4.8 Global Hemophilia B Market by Treatment Regimen
Continued…
Buy the report@https://www.orbisresearch.com/contact/purchase-single-user/3416064
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: [email protected]
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A
Phone: +1 (214) 884-6817
Website: https://www.orbisresearch.com/reports/index/global-hemophilia-market-report-insights-trends-and-forecast-2019-2023
Source: MarketersMedia
Release ID: 88893387
More News
As Political Ad Spending Skyrockets, Broadcast TV Remains King
Even though marketers have increasingly shifted their dollars to other media, local stations are reaping a bonanza during these midterm elections. Nowhere is this is more evident than in Texas.
Chinese, German auto companies boost cooperation amid industry shift
Chinese and German auto companies on Friday explored ways to boost cooperation amid profound global transformation and fierce industry competition.
Crypto firm Binance covers 90% of losses after $6.3bn hack
The Federal Bureau of Investigation (FBI) says North Korea was responsible for the hack.
How Chinese private enterprises thrive in high-quality development
How Chinese private enterprises thrive in high-quality development
Shops looted as German cost-of-living protests turn violent
The protests in cities across Germany - including Berlin, Hamburg and Frankfurt - came on the same day hundreds of thousands also protested in France.
China's draft financial law takes aim at cross-border risks
China's draft financial law takes aim at cross-border risks
ACLU’s Anthony Romero Says CEOs Are ‘Ducking the Hard Issues’
Anthony Romero has led the American Civil Liberties Union since 2001. He worries that Americans have fewer rights now.
Cyril Hilsum, Who Helped Invent Flat-Panel Displays in TVs and iPhones, Has Died at 101
The man who helped develop the technology for liquid crystal displays — the screens in flat-panel televisions and laptops — has died at 101.
US firms lead business sign-ups for APEC CEO Summit in Shenzhen
US firms lead business sign-ups for APEC CEO Summit in Shenzhen
China's top 1,000 private companies: Innovation at a glance
China's top 1,000 private companies are boosting innovation, with R&D spending reaching 1.59 trillion yuan ($239 billion) in 2025, up 10.72% year on year. Their growing investment in research and global expansion is strengthening the country's innovation drive.
Japan nears 2% inflation target, but households struggle
Despite progress toward its long-sought inflation target, Japan continues to grapple with weak purchasing power, rising living costs and structural economic challenges.
US tech stocks hit by earnings shock: Alphabet slides 13%
US technology shares suffered their worst selloff in months last week as a wave of quarterly results disappointed investors worried about whether massive artificial intelligence spending will ever pay off.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.